Home/Filings/4/0001645842-22-000021
4//SEC Filing

Serber Zachariah 4

Accession 0001645842-22-000021

CIK 0001645842other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:53 PM ET

Size

6.6 KB

Accession

0001645842-22-000021

Insider Transaction Report

Form 4
Period: 2022-02-22
Serber Zachariah
DirectorChief Science Officer
Transactions
  • Sale

    Common Stock

    2022-02-22$3.91/sh1,424$5,5682,373,491 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    40,000
  • Common Stock

    (indirect: See Footnote)
    40,000
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2021 that provides for the sale of up to 250,000 shares over the next ten (10) months, which started January 24, 2022.
  • [F2]Held by the Rorik Serber 2021 Irrevocable Trust.
  • [F3]Held by spouse as custodian for children under the California Uniform Transfer to Minors Act.

Issuer

Zymergen Inc.

CIK 0001645842

Entity typeother

Related Parties

1
  • filerCIK 0001845655

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:53 PM ET
Size
6.6 KB